INDO US BIO-TECH | MANGALAM GLOBAL ENTERPRISE | INDO US BIO-TECH/ MANGALAM GLOBAL ENTERPRISE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | 20.8 | 203.7% | View Chart |
P/BV | x | 8.6 | 3.0 | 291.4% | View Chart |
Dividend Yield | % | 0.0 | 0.1 | - |
INDO US BIO-TECH MANGALAM GLOBAL ENTERPRISE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
MANGALAM GLOBAL ENTERPRISE Mar-23 |
INDO US BIO-TECH/ MANGALAM GLOBAL ENTERPRISE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 52 | 239.5% | |
Low | Rs | 25 | 29 | 86.8% | |
Sales per share (Unadj.) | Rs | 61.6 | 102.7 | 59.9% | |
Earnings per share (Unadj.) | Rs | 7.2 | 0.9 | 787.8% | |
Cash flow per share (Unadj.) | Rs | 8.0 | 1.1 | 704.3% | |
Dividends per share (Unadj.) | Rs | 0 | 0.02 | 0.0% | |
Avg Dividend yield | % | 0 | 0 | 0.0% | |
Book value per share (Unadj.) | Rs | 54.3 | 8.2 | 666.5% | |
Shares outstanding (eoy) | m | 10.03 | 138.56 | 7.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 0.4 | 309.1% | |
Avg P/E ratio | x | 10.4 | 44.3 | 23.5% | |
P/CF ratio (eoy) | x | 9.4 | 35.6 | 26.3% | |
Price / Book Value ratio | x | 1.4 | 5.0 | 27.8% | |
Dividend payout | % | 0 | 2.2 | 0.0% | |
Avg Mkt Cap | Rs m | 754 | 5,625 | 13.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 74 | 17.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 14,233 | 4.3% | |
Other income | Rs m | 0 | 52 | 0.4% | |
Total revenues | Rs m | 618 | 14,286 | 4.3% | |
Gross profit | Rs m | 94 | 286 | 32.8% | |
Depreciation | Rs m | 8 | 31 | 26.4% | |
Interest | Rs m | 12 | 147 | 8.2% | |
Profit before tax | Rs m | 74 | 161 | 46.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 34 | 4.3% | |
Profit after tax | Rs m | 72 | 127 | 57.0% | |
Gross profit margin | % | 15.2 | 2.0 | 755.8% | |
Effective tax rate | % | 2.0 | 21.0 | 9.4% | |
Net profit margin | % | 11.7 | 0.9 | 1,314.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 3,414 | 17.5% | |
Current liabilities | Rs m | 123 | 2,937 | 4.2% | |
Net working cap to sales | % | 77.1 | 3.4 | 2,300.8% | |
Current ratio | x | 4.9 | 1.2 | 419.2% | |
Inventory Days | Days | 1 | 1 | 95.6% | |
Debtors Days | Days | 146,261,410 | 538 | 27,198,937.9% | |
Net fixed assets | Rs m | 90 | 806 | 11.1% | |
Share capital | Rs m | 100 | 277 | 36.2% | |
"Free" reserves | Rs m | 445 | 852 | 52.2% | |
Net worth | Rs m | 545 | 1,130 | 48.2% | |
Long term debt | Rs m | 17 | 163 | 10.4% | |
Total assets | Rs m | 689 | 4,219 | 16.3% | |
Interest coverage | x | 7.2 | 2.1 | 341.6% | |
Debt to equity ratio | x | 0 | 0.1 | 21.7% | |
Sales to assets ratio | x | 0.9 | 3.4 | 26.6% | |
Return on assets | % | 12.3 | 6.5 | 188.8% | |
Return on equity | % | 13.3 | 11.2 | 118.2% | |
Return on capital | % | 15.3 | 23.8 | 64.2% | |
Exports to sales | % | 0 | 8.9 | 0.0% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | 1,267 | 0.0% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 1,267 | 0.0% | |
Fx outflow | Rs m | 0 | 12 | 0.0% | |
Net fx | Rs m | 0 | 1,255 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | -672 | -0.8% | |
From Investments | Rs m | -67 | -411 | 16.2% | |
From Financial Activity | Rs m | 63 | 1,091 | 5.8% | |
Net Cashflow | Rs m | 1 | 8 | 17.9% |
Indian Promoters | % | 70.2 | 75.0 | 93.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 25.0 | 119.3% | |
Shareholders | 1,166 | 15,712 | 7.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | MANGALAM GLOBAL ENTERPRISE |
---|---|---|
1-Day | 8.77% | 19.85% |
1-Month | 26.17% | 15.38% |
1-Year | 113.64% | 40.91% |
3-Year CAGR | 152.58% | 35.29% |
5-Year CAGR | 42.16% | -14.71% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the MANGALAM GLOBAL ENTERPRISE share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of MANGALAM GLOBAL ENTERPRISE the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of MANGALAM GLOBAL ENTERPRISE.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
MANGALAM GLOBAL ENTERPRISE paid Rs 0.0, and its dividend payout ratio stood at 2.2%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of MANGALAM GLOBAL ENTERPRISE.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.